Drugs & Targets Loxo Oncology acquires highly selective, reversible BTK inhibitor August 04, 2017Vol.43 No.31
Drugs & Targets MedStar Health partners with Indivumed to advance precision oncology research August 04, 2017Vol.43 No.31
Drugs & Targets FDA approves treatment to reduce risk of breast cancer returning August 03, 2017Vol.40 No.07
Drugs & Targets CHMP issues positive opinion for avelumab for metastatic Merkel cell carcinoma July 28, 2017Vol.43 No.30
Drugs & Targets FDA expands approval of Yervoy to include pediatric patients 12 years and older with unresectable or metastatic melanoma July 28, 2017Vol.43 No.30
Drugs & Targets FDA accepts BMS applications for Opdivo four-week dosing schedule across approved indications July 28, 2017Vol.43 No.30
Drugs & Targets Novartis receives positive CHMP opinion for Rydapt for newly diagnosed FLT3-mutated AML, three types of advanced systemic mastocytosis July 28, 2017Vol.43 No.30
Drugs & TargetsFree FDA approves treatment to reduce risk of breast cancer returning July 21, 2017Vol.43 No.29
Drugs & TargetsFree FDA accepts for priority review BMS application for dasatinib in children with CP Ph+ CML July 21, 2017Vol.43 No.29
